nodes	percent_of_prediction	percent_of_DWPC	metapath
Methysergide—HTR2A—chronic obstructive pulmonary disease	0.649	1	CbGaD
Methysergide—HTR2A—phrenic nerve—chronic obstructive pulmonary disease	0.0186	0.316	CbGeAlD
Methysergide—HTR7—pulmonary artery—chronic obstructive pulmonary disease	0.0109	0.184	CbGeAlD
Methysergide—HTR2A—pulmonary artery—chronic obstructive pulmonary disease	0.00677	0.115	CbGeAlD
Methysergide—Cardiac murmur—Salbutamol—chronic obstructive pulmonary disease	0.00625	0.0323	CcSEcCtD
Methysergide—Leg pain—Tiotropium—chronic obstructive pulmonary disease	0.00551	0.0284	CcSEcCtD
Methysergide—Heartburn—Aminophylline—chronic obstructive pulmonary disease	0.00392	0.0202	CcSEcCtD
Methysergide—Telangiectasia—Prednisone—chronic obstructive pulmonary disease	0.00343	0.0177	CcSEcCtD
Methysergide—Gastrointestinal symptom NOS—Salbutamol—chronic obstructive pulmonary disease	0.00329	0.017	CcSEcCtD
Methysergide—Heartburn—Salbutamol—chronic obstructive pulmonary disease	0.00281	0.0145	CcSEcCtD
Methysergide—Hyperaesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00247	0.0127	CcSEcCtD
Methysergide—Mydriasis—Salbutamol—chronic obstructive pulmonary disease	0.00243	0.0125	CcSEcCtD
Methysergide—Lightheadedness—Aminophylline—chronic obstructive pulmonary disease	0.00241	0.0125	CcSEcCtD
Methysergide—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.00229	0.0118	CcSEcCtD
Methysergide—Polyuria—Aminophylline—chronic obstructive pulmonary disease	0.00223	0.0115	CcSEcCtD
Methysergide—HTR1D—connective tissue—chronic obstructive pulmonary disease	0.00202	0.0342	CbGeAlD
Methysergide—Pain in extremity—Tiotropium—chronic obstructive pulmonary disease	0.00185	0.00953	CcSEcCtD
Methysergide—HTR7—respiratory system—chronic obstructive pulmonary disease	0.00183	0.0309	CbGeAlD
Methysergide—SIGMAR1—bronchus—chronic obstructive pulmonary disease	0.00176	0.0298	CbGeAlD
Methysergide—Lightheadedness—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00895	CcSEcCtD
Methysergide—SIGMAR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00172	0.0291	CbGeAlD
Methysergide—HTR2B—smooth muscle tissue—chronic obstructive pulmonary disease	0.00172	0.0291	CbGeAlD
Methysergide—Back pain—Roflumilast—chronic obstructive pulmonary disease	0.00171	0.00883	CcSEcCtD
Methysergide—Euphoric mood—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00859	CcSEcCtD
Methysergide—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.00164	0.00847	CcSEcCtD
Methysergide—HTR7—connective tissue—chronic obstructive pulmonary disease	0.00161	0.0272	CbGeAlD
Methysergide—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00159	0.00823	CcSEcCtD
Methysergide—SIGMAR1—trachea—chronic obstructive pulmonary disease	0.00158	0.0267	CbGeAlD
Methysergide—Myalgia—Roflumilast—chronic obstructive pulmonary disease	0.0015	0.00777	CcSEcCtD
Methysergide—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.00149	0.0077	CcSEcCtD
Methysergide—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00149	0.00767	CcSEcCtD
Methysergide—HTR7—smooth muscle tissue—chronic obstructive pulmonary disease	0.00147	0.0249	CbGeAlD
Methysergide—Methylergometrine—HTR2A—chronic obstructive pulmonary disease	0.00143	0.225	CrCbGaD
Methysergide—Mydriasis—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.00719	CcSEcCtD
Methysergide—HTR7—trachea—chronic obstructive pulmonary disease	0.00135	0.0229	CbGeAlD
Methysergide—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.00683	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00131	0.00678	CcSEcCtD
Methysergide—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.0013	0.00673	CcSEcCtD
Methysergide—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00127	0.00655	CcSEcCtD
Methysergide—Oedema peripheral—Tiotropium—chronic obstructive pulmonary disease	0.00126	0.00649	CcSEcCtD
Methysergide—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00126	0.00649	CcSEcCtD
Methysergide—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00644	CcSEcCtD
Methysergide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00643	CcSEcCtD
Methysergide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00124	0.00642	CcSEcCtD
Methysergide—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00123	0.00637	CcSEcCtD
Methysergide—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.0012	0.00618	CcSEcCtD
Methysergide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00119	0.00614	CcSEcCtD
Methysergide—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00118	0.00609	CcSEcCtD
Methysergide—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00114	0.00589	CcSEcCtD
Methysergide—HTR2A—respiratory system—chronic obstructive pulmonary disease	0.00114	0.0193	CbGeAlD
Methysergide—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00587	CcSEcCtD
Methysergide—SIGMAR1—lung—chronic obstructive pulmonary disease	0.00113	0.0192	CbGeAlD
Methysergide—HTR2B—lung—chronic obstructive pulmonary disease	0.00113	0.0192	CbGeAlD
Methysergide—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00112	0.0058	CcSEcCtD
Methysergide—Ergotamine—CYP1A2—chronic obstructive pulmonary disease	0.00109	0.172	CrCbGaD
Methysergide—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00559	CcSEcCtD
Methysergide—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00107	0.00555	CcSEcCtD
Methysergide—Bromocriptine—CYP1A2—chronic obstructive pulmonary disease	0.00105	0.166	CrCbGaD
Methysergide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00103	0.00534	CcSEcCtD
Methysergide—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00102	0.00527	CcSEcCtD
Methysergide—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.00101	0.00524	CcSEcCtD
Methysergide—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.00101	0.00524	CcSEcCtD
Methysergide—HTR2A—connective tissue—chronic obstructive pulmonary disease	0.001	0.017	CbGeAlD
Methysergide—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000987	0.00509	CcSEcCtD
Methysergide—HTR7—lung—chronic obstructive pulmonary disease	0.000969	0.0164	CbGeAlD
Methysergide—Lisuride—HTR2A—chronic obstructive pulmonary disease	0.000958	0.151	CrCbGaD
Methysergide—Euphoric mood—Prednisolone—chronic obstructive pulmonary disease	0.000955	0.00493	CcSEcCtD
Methysergide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000954	0.00492	CcSEcCtD
Methysergide—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000946	0.00488	CcSEcCtD
Methysergide—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000946	0.00488	CcSEcCtD
Methysergide—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000946	0.00488	CcSEcCtD
Methysergide—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000939	0.00485	CcSEcCtD
Methysergide—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.000932	0.00481	CcSEcCtD
Methysergide—Ergotamine—HTR2A—chronic obstructive pulmonary disease	0.00092	0.145	CrCbGaD
Methysergide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000917	0.00473	CcSEcCtD
Methysergide—HTR2A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000917	0.0155	CbGeAlD
Methysergide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000909	0.00469	CcSEcCtD
Methysergide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000909	0.00469	CcSEcCtD
Methysergide—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000907	0.00468	CcSEcCtD
Methysergide—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000903	0.00466	CcSEcCtD
Methysergide—Bromocriptine—HTR2A—chronic obstructive pulmonary disease	0.000887	0.14	CrCbGaD
Methysergide—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000885	0.00457	CcSEcCtD
Methysergide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00087	0.00449	CcSEcCtD
Methysergide—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000868	0.00448	CcSEcCtD
Methysergide—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000868	0.00448	CcSEcCtD
Methysergide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000857	0.00442	CcSEcCtD
Methysergide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000847	0.00437	CcSEcCtD
Methysergide—HTR2A—trachea—chronic obstructive pulmonary disease	0.000841	0.0142	CbGeAlD
Methysergide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000832	0.0043	CcSEcCtD
Methysergide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000832	0.0043	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000826	0.00427	CcSEcCtD
Methysergide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00082	0.00424	CcSEcCtD
Methysergide—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000819	0.00423	CcSEcCtD
Methysergide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000814	0.0042	CcSEcCtD
Methysergide—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000809	0.00418	CcSEcCtD
Methysergide—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000809	0.00418	CcSEcCtD
Methysergide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000798	0.00412	CcSEcCtD
Methysergide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000786	0.00406	CcSEcCtD
Methysergide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000786	0.00406	CcSEcCtD
Methysergide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000783	0.00404	CcSEcCtD
Methysergide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000776	0.004	CcSEcCtD
Methysergide—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.000764	0.00394	CcSEcCtD
Methysergide—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000764	0.00394	CcSEcCtD
Methysergide—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000764	0.00394	CcSEcCtD
Methysergide—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000764	0.00394	CcSEcCtD
Methysergide—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000764	0.00394	CcSEcCtD
Methysergide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000764	0.00394	CcSEcCtD
Methysergide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000764	0.00394	CcSEcCtD
Methysergide—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000761	0.00393	CcSEcCtD
Methysergide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00076	0.00393	CcSEcCtD
Methysergide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00076	0.00393	CcSEcCtD
Methysergide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000754	0.00389	CcSEcCtD
Methysergide—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000754	0.00389	CcSEcCtD
Methysergide—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000748	0.00386	CcSEcCtD
Methysergide—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000748	0.00386	CcSEcCtD
Methysergide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000742	0.00383	CcSEcCtD
Methysergide—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000732	0.00378	CcSEcCtD
Methysergide—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000732	0.00378	CcSEcCtD
Methysergide—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000721	0.00372	CcSEcCtD
Methysergide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000721	0.00372	CcSEcCtD
Methysergide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000721	0.00372	CcSEcCtD
Methysergide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000717	0.0037	CcSEcCtD
Methysergide—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000717	0.0037	CcSEcCtD
Methysergide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000714	0.00369	CcSEcCtD
Methysergide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000714	0.00369	CcSEcCtD
Methysergide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000712	0.00368	CcSEcCtD
Methysergide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000702	0.00362	CcSEcCtD
Methysergide—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.000694	0.00358	CcSEcCtD
Methysergide—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000691	0.00357	CcSEcCtD
Methysergide—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000677	0.0035	CcSEcCtD
Methysergide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000675	0.00348	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000667	0.00344	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000667	0.00344	CcSEcCtD
Methysergide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000662	0.00342	CcSEcCtD
Methysergide—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000662	0.00342	CcSEcCtD
Methysergide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000658	0.0034	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000653	0.00337	CcSEcCtD
Methysergide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000653	0.00337	CcSEcCtD
Methysergide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000653	0.00337	CcSEcCtD
Methysergide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000651	0.00336	CcSEcCtD
Methysergide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000651	0.00336	CcSEcCtD
Methysergide—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000648	0.00335	CcSEcCtD
Methysergide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000644	0.00333	CcSEcCtD
Methysergide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000644	0.00333	CcSEcCtD
Methysergide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000644	0.00332	CcSEcCtD
Methysergide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000637	0.00329	CcSEcCtD
Methysergide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000636	0.00328	CcSEcCtD
Methysergide—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000634	0.00328	CcSEcCtD
Methysergide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000632	0.00326	CcSEcCtD
Methysergide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000632	0.00326	CcSEcCtD
Methysergide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000631	0.00326	CcSEcCtD
Methysergide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000631	0.00326	CcSEcCtD
Methysergide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000631	0.00326	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00063	0.00325	CcSEcCtD
Methysergide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000626	0.00323	CcSEcCtD
Methysergide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000626	0.00323	CcSEcCtD
Methysergide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000626	0.00323	CcSEcCtD
Methysergide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000626	0.00323	CcSEcCtD
Methysergide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000625	0.00323	CcSEcCtD
Methysergide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000621	0.0032	CcSEcCtD
Methysergide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000619	0.0032	CcSEcCtD
Methysergide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000618	0.00319	CcSEcCtD
Methysergide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000616	0.00318	CcSEcCtD
Methysergide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000614	0.00317	CcSEcCtD
Methysergide—Pain—Montelukast—chronic obstructive pulmonary disease	0.000613	0.00317	CcSEcCtD
Methysergide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000612	0.00316	CcSEcCtD
Methysergide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000608	0.00314	CcSEcCtD
Methysergide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000606	0.00313	CcSEcCtD
Methysergide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000606	0.00313	CcSEcCtD
Methysergide—HTR2A—lung—chronic obstructive pulmonary disease	0.000605	0.0102	CbGeAlD
Methysergide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000603	0.00311	CcSEcCtD
Methysergide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000603	0.00311	CcSEcCtD
Methysergide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0006	0.0031	CcSEcCtD
Methysergide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000599	0.00309	CcSEcCtD
Methysergide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000599	0.00309	CcSEcCtD
Methysergide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000597	0.00308	CcSEcCtD
Methysergide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000596	0.00308	CcSEcCtD
Methysergide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000591	0.00305	CcSEcCtD
Methysergide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000591	0.00305	CcSEcCtD
Methysergide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000586	0.00303	CcSEcCtD
Methysergide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000579	0.00299	CcSEcCtD
Methysergide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000579	0.00299	CcSEcCtD
Methysergide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000579	0.00299	CcSEcCtD
Methysergide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000579	0.00299	CcSEcCtD
Methysergide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000577	0.00298	CcSEcCtD
Methysergide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000572	0.00295	CcSEcCtD
Methysergide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000571	0.00295	CcSEcCtD
Methysergide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000571	0.00295	CcSEcCtD
Methysergide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00057	0.00294	CcSEcCtD
Methysergide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000567	0.00293	CcSEcCtD
Methysergide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000567	0.00293	CcSEcCtD
Methysergide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000565	0.00292	CcSEcCtD
Methysergide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000546	0.00282	CcSEcCtD
Methysergide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000546	0.00282	CcSEcCtD
Methysergide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000539	0.00278	CcSEcCtD
Methysergide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000525	0.00271	CcSEcCtD
Methysergide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000525	0.00271	CcSEcCtD
Methysergide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000514	0.00266	CcSEcCtD
Methysergide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000501	0.00259	CcSEcCtD
Methysergide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000501	0.00259	CcSEcCtD
Methysergide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000496	0.00256	CcSEcCtD
Methysergide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000491	0.00253	CcSEcCtD
Methysergide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000484	0.0025	CcSEcCtD
Methysergide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000484	0.0025	CcSEcCtD
Methysergide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000474	0.00245	CcSEcCtD
Methysergide—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000474	0.00245	CcSEcCtD
Methysergide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000473	0.00244	CcSEcCtD
Methysergide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000465	0.0024	CcSEcCtD
Methysergide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000465	0.0024	CcSEcCtD
Methysergide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000462	0.00238	CcSEcCtD
Methysergide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000462	0.00238	CcSEcCtD
Methysergide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000461	0.00238	CcSEcCtD
Methysergide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000461	0.00238	CcSEcCtD
Methysergide—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000461	0.00238	CcSEcCtD
Methysergide—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000458	0.00237	CcSEcCtD
Methysergide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000457	0.00236	CcSEcCtD
Methysergide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000456	0.00235	CcSEcCtD
Methysergide—Rash—Montelukast—chronic obstructive pulmonary disease	0.000452	0.00233	CcSEcCtD
Methysergide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000452	0.00233	CcSEcCtD
Methysergide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000451	0.00233	CcSEcCtD
Methysergide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000439	0.00227	CcSEcCtD
Methysergide—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000438	0.00226	CcSEcCtD
Methysergide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000436	0.00225	CcSEcCtD
Methysergide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.00225	CcSEcCtD
Methysergide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000435	0.00224	CcSEcCtD
Methysergide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.00224	CcSEcCtD
Methysergide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000426	0.0022	CcSEcCtD
Methysergide—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000421	0.00217	CcSEcCtD
Methysergide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00212	CcSEcCtD
Methysergide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000409	0.00211	CcSEcCtD
Methysergide—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000396	0.00205	CcSEcCtD
Methysergide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000387	0.002	CcSEcCtD
Methysergide—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000376	0.00194	CcSEcCtD
Methysergide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000359	0.00185	CcSEcCtD
Methysergide—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000358	0.00185	CcSEcCtD
Methysergide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000356	0.00184	CcSEcCtD
Methysergide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000339	0.00175	CcSEcCtD
Methysergide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000327	0.00169	CcSEcCtD
Methysergide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000327	0.00169	CcSEcCtD
Methysergide—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000318	0.00164	CcSEcCtD
Methysergide—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000306	0.00158	CcSEcCtD
Methysergide—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.0003	0.00155	CcSEcCtD
Methysergide—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.0003	0.00155	CcSEcCtD
Methysergide—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000297	0.00153	CcSEcCtD
Methysergide—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000288	0.00149	CcSEcCtD
Methysergide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000281	0.00145	CcSEcCtD
Methysergide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000262	0.00135	CcSEcCtD
Methysergide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000262	0.00135	CcSEcCtD
Methysergide—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000261	0.00135	CcSEcCtD
Methysergide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00134	CcSEcCtD
Methysergide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000254	0.00131	CcSEcCtD
Methysergide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00025	0.00129	CcSEcCtD
Methysergide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00025	0.00129	CcSEcCtD
Methysergide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000248	0.00128	CcSEcCtD
Methysergide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000246	0.00127	CcSEcCtD
Methysergide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000237	0.00123	CcSEcCtD
Methysergide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000236	0.00122	CcSEcCtD
Methysergide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000235	0.00122	CcSEcCtD
Methysergide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000228	0.00118	CcSEcCtD
Methysergide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000228	0.00118	CcSEcCtD
Methysergide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000207	0.00107	CcSEcCtD
Methysergide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000197	0.00102	CcSEcCtD
Methysergide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00019	0.000983	CcSEcCtD
Methysergide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000946	CcSEcCtD
Methysergide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000938	CcSEcCtD
Methysergide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000937	CcSEcCtD
Methysergide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000883	CcSEcCtD
Methysergide—HTR1B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	5.29e-05	0.000576	CbGpPWpGaD
Methysergide—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.29e-05	0.000576	CbGpPWpGaD
Methysergide—HTR1B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	5.28e-05	0.000576	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	5.28e-05	0.000575	CbGpPWpGaD
Methysergide—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	5.26e-05	0.000573	CbGpPWpGaD
Methysergide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	5.19e-05	0.000566	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	5.19e-05	0.000566	CbGpPWpGaD
Methysergide—HTR1A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.18e-05	0.000565	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.16e-05	0.000563	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.16e-05	0.000562	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.12e-05	0.000559	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	5.02e-05	0.000547	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	5e-05	0.000545	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5e-05	0.000545	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.97e-05	0.000542	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.97e-05	0.000542	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.97e-05	0.000542	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.97e-05	0.000541	CbGpPWpGaD
Methysergide—HTR2B—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.96e-05	0.000541	CbGpPWpGaD
Methysergide—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	4.95e-05	0.000539	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.94e-05	0.000538	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.83e-05	0.000527	CbGpPWpGaD
Methysergide—HTR1F—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.77e-05	0.00052	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.73e-05	0.000516	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	4.71e-05	0.000514	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.71e-05	0.000514	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.69e-05	0.000511	CbGpPWpGaD
Methysergide—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	4.57e-05	0.000498	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	4.54e-05	0.000495	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.52e-05	0.000492	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.51e-05	0.000492	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	4.51e-05	0.000491	CbGpPWpGaD
Methysergide—HTR1E—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.5e-05	0.00049	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.48e-05	0.000489	CbGpPWpGaD
Methysergide—HTR2A—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	4.48e-05	0.000488	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.47e-05	0.000487	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.39e-05	0.000479	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.33e-05	0.000472	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	4.32e-05	0.000471	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.3e-05	0.000469	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.28e-05	0.000466	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.26e-05	0.000464	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.21e-05	0.000459	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.19e-05	0.000457	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.14e-05	0.000451	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.12e-05	0.00045	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.09e-05	0.000445	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.07e-05	0.000444	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.06e-05	0.000442	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.03e-05	0.000439	CbGpPWpGaD
Methysergide—HTR1A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.03e-05	0.000439	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	4.01e-05	0.000437	CbGpPWpGaD
Methysergide—HTR2C—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	4.01e-05	0.000437	CbGpPWpGaD
Methysergide—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.99e-05	0.000435	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.98e-05	0.000434	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.97e-05	0.000433	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.95e-05	0.00043	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.91e-05	0.000426	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.87e-05	0.000421	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.85e-05	0.00042	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.82e-05	0.000417	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.8e-05	0.000415	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.7e-05	0.000403	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	3.7e-05	0.000403	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.7e-05	0.000403	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.68e-05	0.000401	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.67e-05	0.0004	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.66e-05	0.000399	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	3.64e-05	0.000396	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.63e-05	0.000396	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.63e-05	0.000396	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.59e-05	0.000392	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.48e-05	0.000379	CbGpPWpGaD
Methysergide—HTR2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.48e-05	0.000379	CbGpPWpGaD
Methysergide—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.46e-05	0.000378	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.41e-05	0.000372	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.41e-05	0.000372	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.39e-05	0.000369	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.38e-05	0.000368	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.34e-05	0.000365	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.33e-05	0.000363	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.32e-05	0.000362	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.3e-05	0.00036	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.17e-05	0.000345	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.12e-05	0.00034	CbGpPWpGaD
Methysergide—HTR6—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.07e-05	0.000335	CbGpPWpGaD
Methysergide—HTR7—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.07e-05	0.000335	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.05e-05	0.000333	CbGpPWpGaD
Methysergide—HTR1D—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.05e-05	0.000332	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.05e-05	0.000332	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.03e-05	0.00033	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.02e-05	0.000329	CbGpPWpGaD
Methysergide—HTR1B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.99e-05	0.000326	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.99e-05	0.000326	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.96e-05	0.000323	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.95e-05	0.000321	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.93e-05	0.000319	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.88e-05	0.000314	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.85e-05	0.000311	CbGpPWpGaD
Methysergide—HTR2B—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.81e-05	0.000306	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.79e-05	0.000304	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.79e-05	0.000304	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.78e-05	0.000304	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.77e-05	0.000302	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.77e-05	0.000302	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.77e-05	0.000302	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.75e-05	0.0003	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.74e-05	0.000298	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.72e-05	0.000297	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.72e-05	0.000297	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.71e-05	0.000296	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.69e-05	0.000294	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.67e-05	0.000291	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.67e-05	0.000291	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.65e-05	0.000289	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.59e-05	0.000283	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.56e-05	0.000279	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.55e-05	0.000278	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.54e-05	0.000277	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.53e-05	0.000276	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.53e-05	0.000275	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.51e-05	0.000274	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.48e-05	0.00027	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.48e-05	0.00027	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.46e-05	0.000268	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.44e-05	0.000266	CbGpPWpGaD
Methysergide—HTR1F—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.43e-05	0.000265	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.41e-05	0.000263	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.41e-05	0.000263	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.37e-05	0.000258	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.31e-05	0.000252	CbGpPWpGaD
Methysergide—HTR1E—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.3e-05	0.00025	CbGpPWpGaD
Methysergide—HTR1A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.28e-05	0.000248	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.26e-05	0.000247	CbGpPWpGaD
Methysergide—HTR2C—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.26e-05	0.000247	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.26e-05	0.000246	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.25e-05	0.000245	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.18e-05	0.000238	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.18e-05	0.000238	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.08e-05	0.000227	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.07e-05	0.000225	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.06e-05	0.000224	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.05e-05	0.000224	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.04e-05	0.000223	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.04e-05	0.000222	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.04e-05	0.000222	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.02e-05	0.000221	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.98e-05	0.000216	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.98e-05	0.000215	CbGpPWpGaD
Methysergide—HTR2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.97e-05	0.000214	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.97e-05	0.000214	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.96e-05	0.000214	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.95e-05	0.000213	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.95e-05	0.000212	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.94e-05	0.000212	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.93e-05	0.000211	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.91e-05	0.000208	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.89e-05	0.000206	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.87e-05	0.000204	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.86e-05	0.000203	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.86e-05	0.000203	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.86e-05	0.000202	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.84e-05	0.000201	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.84e-05	0.0002	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.83e-05	0.000199	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.81e-05	0.000197	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.8e-05	0.000196	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.78e-05	0.000195	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.78e-05	0.000194	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.77e-05	0.000193	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.76e-05	0.000192	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.7e-05	0.000185	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.65e-05	0.00018	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.65e-05	0.00018	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.64e-05	0.000178	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.6e-05	0.000175	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.59e-05	0.000173	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.57e-05	0.000171	CbGpPWpGaD
Methysergide—HTR6—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.57e-05	0.000171	CbGpPWpGaD
Methysergide—HTR7—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.57e-05	0.000171	CbGpPWpGaD
Methysergide—HTR1D—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.56e-05	0.00017	CbGpPWpGaD
Methysergide—HTR1B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.52e-05	0.000166	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.51e-05	0.000165	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.51e-05	0.000164	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.5e-05	0.000164	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.49e-05	0.000163	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.49e-05	0.000162	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.48e-05	0.000161	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.48e-05	0.000161	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.45e-05	0.000158	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.44e-05	0.000157	CbGpPWpGaD
Methysergide—HTR1F—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.44e-05	0.000157	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.43e-05	0.000156	CbGpPWpGaD
Methysergide—HTR2B—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.43e-05	0.000156	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.38e-05	0.00015	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.37e-05	0.000149	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.36e-05	0.000148	CbGpPWpGaD
Methysergide—HTR1E—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.36e-05	0.000148	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.34e-05	0.000146	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.34e-05	0.000146	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.33e-05	0.000145	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.3e-05	0.000142	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.3e-05	0.000142	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.25e-05	0.000136	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.23e-05	0.000134	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.23e-05	0.000134	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.22e-05	0.000133	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.22e-05	0.000133	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.22e-05	0.000133	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.21e-05	0.000132	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.21e-05	0.000131	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.000131	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.00013	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.19e-05	0.00013	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.19e-05	0.00013	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.17e-05	0.000128	CbGpPWpGaD
Methysergide—HTR1A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.16e-05	0.000127	CbGpPWpGaD
Methysergide—HTR2C—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.15e-05	0.000126	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.12e-05	0.000122	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.1e-05	0.00012	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.1e-05	0.00012	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.1e-05	0.00012	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.05e-05	0.000115	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.01e-05	0.00011	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.01e-05	0.00011	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1e-05	0.000109	CbGpPWpGaD
Methysergide—HTR2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1e-05	0.000109	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.91e-06	0.000108	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.86e-06	0.000107	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.83e-06	0.000107	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	9.54e-06	0.000104	CbGpPWpGaD
Methysergide—HTR6—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.26e-06	0.000101	CbGpPWpGaD
Methysergide—HTR7—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.25e-06	0.000101	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	9.24e-06	0.000101	CbGpPWpGaD
Methysergide—HTR1D—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.19e-06	0.0001	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.1e-06	9.92e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	9.05e-06	9.87e-05	CbGpPWpGaD
Methysergide—HTR1B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9e-06	9.81e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.92e-06	9.72e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.87e-06	9.67e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	8.56e-06	9.34e-05	CbGpPWpGaD
Methysergide—HTR2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	8.45e-06	9.22e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	7.86e-06	8.57e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	7.71e-06	8.4e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.49e-06	8.16e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.45e-06	8.12e-05	CbGpPWpGaD
Methysergide—HTR1A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.86e-06	7.47e-05	CbGpPWpGaD
Methysergide—HTR2C—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.82e-06	7.43e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	6.47e-06	7.05e-05	CbGpPWpGaD
Methysergide—HTR2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	5.92e-06	6.46e-05	CbGpPWpGaD
